{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:47:37Z","timestamp":1788810457208,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Science and Technology Major Projects for the Major New Drugs Innovation and Development","award":["2018ZX09721002-009"],"award-info":[{"award-number":["2018ZX09721002-009"]}]},{"name":"Strategic Priority Research Program of Chinese Academy of Sciences","award":["XDA12050307"],"award-info":[{"award-number":["XDA12050307"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81430087"],"award-info":[{"award-number":["81430087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2017M610284"],"award-info":[{"award-number":["2017M610284"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.apsb.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T12:54:58Z","timestamp":1536324898000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"title":["Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan"],"prefix":"10.1016","volume":"9","author":[{"given":"Yuanzhi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikramjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-0908","authenticated-orcid":false,"given":"Ruxandra","family":"Gref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2018.09.003_bib1","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1002\/adma.201601133","article-title":"Emerging multifunctional metal-organic framework materials","volume":"28","author":"Li","year":"2016","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2018.09.003_bib2","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/anie.200300610","article-title":"Functional porous coordination polymers","volume":"43","author":"Kitagawa","year":"2004","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2018.09.003_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acs.chemmater.6b02626","article-title":"Best practices for the synthesis, activation, and characterization of metal\u2013organic frameworks","volume":"29","author":"Howarth","year":"2017","journal-title":"Chem Mater"},{"key":"10.1016\/j.apsb.2018.09.003_bib4","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/acs.nanolett.6b05004","article-title":"High-performance energy storage and conversion materials derived from a single metal-organic framework\/graphene aerogel composite","volume":"17","author":"Xia","year":"2017","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2018.09.003_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/cr200324t","article-title":"Metal-organic framework materials as chemical sensors","volume":"112","author":"Kreno","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2018.09.003_bib6","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1039\/C5CS00040H","article-title":"Gas sensing using porous materials for automotive applications","volume":"44","author":"Wales","year":"2015","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2018.09.003_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1039\/C3SC52633J","article-title":"Evaluating metal-organic frameworks for natural gas storage","volume":"5","author":"Mason","year":"2014","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2018.09.003_bib8","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1039\/b802426j","article-title":"Selective gas adsorption and separation in metal-organic frameworks","volume":"38","author":"Li","year":"2009","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2018.09.003_bib9","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1021\/jacs.5b12860","article-title":"CD-MOF: a versatile separation medium","volume":"138","author":"Hartlieb","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2018.09.003_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.chroma.2017.01.062","article-title":"Evaluation of drug loading capabilities of gamma-cyclodextrin-metal organic frameworks by high performance liquid chromatography","volume":"1488","author":"Xu","year":"2017","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.apsb.2018.09.003_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/cs400959k","article-title":"Llabr\u00e9s i Xamena FX. Metal organic framework catalysis: quo vadis?","volume":"4","author":"Gascon","year":"2013","journal-title":"ACS Catal"},{"key":"10.1016\/j.apsb.2018.09.003_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.matlet.2016.12.054","article-title":"Template synthesis of micro\/mesoporous Cl-doped polypyrrole using vapor phase polymerization","volume":"192","author":"Bui","year":"2017","journal-title":"Mater Lett"},{"key":"10.1016\/j.apsb.2018.09.003_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/17425247.2013.741583","article-title":"Metal-organic frameworks as potential drug delivery systems","volume":"10","author":"Sun","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2018.09.003_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nmat2608","article-title":"Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging","volume":"9","author":"Horcajada","year":"2010","journal-title":"Nat Mater"},{"key":"10.1016\/j.apsb.2018.09.003_bib15","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1039\/c001181a","article-title":"Biodegradable therapeutic MOFs for the delivery of bioactive molecules","volume":"46","author":"Miller","year":"2010","journal-title":"Chem Commun"},{"key":"10.1016\/j.apsb.2018.09.003_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhazmat.2014.02.026","article-title":"Toxic effect of zinc nanoscale metal-organic frameworks on rat pheochromocytoma (PC12) cells in vitro","volume":"271","author":"Ren","year":"2014","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.apsb.2018.09.003_bib17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1039\/c3sc22116d","article-title":"In depth analysis of the in vivo toxicity of nanoparticles of porous iron(iii) metal-organic frameworks","volume":"4","author":"Baati","year":"2013","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2018.09.003_bib18","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1021\/nl5026419","article-title":"One-pot synthesis of protein-embedded metal-organic frameworks with enhanced biological activities","volume":"14","author":"Lyu","year":"2014","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2018.09.003_bib19","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1021\/jm5004107","article-title":"A low cytotoxic cationic metal-organic framework carrier for controllable drug release","volume":"57","author":"Hu","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2018.09.003_bib20","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1002\/anie.201002343","article-title":"Metal-organic frameworks from edible natural products","volume":"49","author":"Smaldone","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2018.09.003_bib21","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1002\/anie.201702162","article-title":"MOF-templated synthesis of ultrasmall photoluminescent carbon-nanodot arrays for optical applications","volume":"56","author":"Gu","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2018.09.003_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2018.09.003_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10717544.2014.904455","article-title":"Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate\u2013chitosan conjugates","volume":"23","author":"Li","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2018.09.003_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11095-016-2059-1","article-title":"Improvement in thermal stability of sucralose by gamma-cyclodextrin metal-organic frameworks","volume":"34","author":"Lv","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2018.09.003_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acs.molpharmaceut.7b00168","article-title":"Encapsulation of ibuprofen in CD-MOF and related bioavailability studies","volume":"14","author":"Hartlieb","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2018.09.003_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2016.09.029","article-title":"Optimized synthesis and crystalline stability of \u03b3-cyclodextrin metal-organic frameworks for drug adsorption","volume":"514","author":"Liu","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2018.09.003_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.foodchem.2016.06.013","article-title":"Encapsulation of curcumin in cyclodextrin-metal organic frameworks: dissociation of loaded CD-MOFs enhances stability of curcumin","volume":"212","author":"Moussa","year":"2016","journal-title":"Food Chem"},{"key":"10.1016\/j.apsb.2018.09.003_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2018.09.003_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.110.163402","article-title":"Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension","volume":"57","author":"White","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.apsb.2018.09.003_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.110.176636","article-title":"In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies","volume":"336","author":"Ojima","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2018.09.003_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1208\/s12249-016-0531-1","article-title":"Study on enhanced dissolution of azilsartan-loaded solid dispersion, prepared by combining wet milling and spray-drying technologies","volume":"18","author":"Lu","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2018.09.003_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/00498254.2012.708797","article-title":"Absorption of TAK-491, a new angiotensin II receptor antagonist, in animals","volume":"43","author":"Kawaguchi","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.apsb.2018.09.003_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425255.2013.769521","article-title":"Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension","volume":"9","author":"Angeli","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2018.09.003_bib34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2018.09.003_bib35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.apsb.2016.09.005","article-title":"Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles","volume":"7","author":"Shekhawat","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2018.09.003_bib36","doi-asserted-by":"crossref","unstructured":"Ahire E, Thakkar S, Darshanwad M, Misra M. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Acta Pharm Sin B 2018. Available form: http:\/\/dx.doi.org\/10.1016\/j.apsb.2018.07.011","DOI":"10.1016\/j.apsb.2018.07.011"},{"key":"10.1016\/j.apsb.2018.09.003_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2017.06.003","article-title":"Nanosizing techniques for improving bioavailability of drugs","volume":"260","author":"Al-Kassas","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2018.09.003_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drudis.2013.08.014","article-title":"Chemistry-enabled drug delivery (prodrugs): recent progress and challenges","volume":"19","author":"Clas","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2018.09.003_bib39","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1021\/jp4061413","article-title":"Ionic liquid expedites partition of curcumin into solid gel phase but discourages partition into liquid crystalline phase of 1,2-dimyristoyl-sn-glycero-3-phosphocholinesn liposomes","volume":"117","author":"El Khoury","year":"2013","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.apsb.2018.09.003_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.07.015","article-title":"Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations","volume":"453","author":"Paudel","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2018.09.003_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.apsb.2016.03.003","article-title":"Sodium dodecyl sulfate\/\u03b2-cyclodextrin vesicles embedded in chitosan gel for insulin delivery with pH-selective release","volume":"6","author":"Li","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2018.09.003_bib42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/CRD.0b013e31822e9ba3","article-title":"Azilsartan: a newly approved angiotensin II receptor blocker","volume":"19","author":"Lam","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.apsb.2018.09.003_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/01480545.2016.1188301","article-title":"Antihypertensive efficacy and safety of the angiotensin receptor blocker azilsartan in elderly patients with hypertension","volume":"40","author":"Kamada","year":"2017","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.apsb.2018.09.003_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fphar.2016.00235","article-title":"Azilsartan as a potent antihypertensive drug with possible pleiotropic cardiometabolic effects: a review study","volume":"7","author":"Georgiopoulos","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2018.09.003_bib45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/hr.2014.118","article-title":"Possible benefits of azilsartan compared with other angiotensin II type 1 receptor blockers","volume":"37","author":"Miura","year":"2014","journal-title":"Hypertens Res"},{"key":"10.1016\/j.apsb.2018.09.003_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.molstruc.2017.02.063","article-title":"Solvent effect on the self-assembly of salt solvates of an antihypertensive drug azilsartan and 2-methylimidazole","volume":"1137","author":"Zhang","year":"2017","journal-title":"J Mol Struct"},{"key":"10.1016\/j.apsb.2018.09.003_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2018.09.003_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/3-540-16904-0_14","article-title":"A new treatment of chemical reactivity: development of EROS, an expert system for reaction prediction and synthesis design","volume":"137","author":"Gasteiger","year":"1987","journal-title":"Top Curr Chem"},{"key":"10.1016\/j.apsb.2018.09.003_bib49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.molpharmaceut.7b01007","article-title":"Microstructure of pharmaceutical semicrystalline dispersions: the significance of polymer conformation","volume":"15","author":"Van Duong","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2018.09.003_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cattod.2012.08.044","article-title":"Small-angle X-ray scattering documents the growth of metal-organic frameworks","volume":"205","author":"Goesten","year":"2013","journal-title":"Catal Today"},{"key":"10.1016\/j.apsb.2018.09.003_bib51","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semiempirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2018.09.003_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2018.09.003_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2016.01.062","article-title":"Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions","volume":"503","author":"Sun","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2018.09.003_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2016.11.049","article-title":"Experimental observations and dissipative particle dynamic simulations on microstructures of pH-sensitive polymer containing amorphous solid dispersions","volume":"517","author":"Sun","year":"2017","journal-title":"Int J Pharm"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383518303745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383518303745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:40:54Z","timestamp":1761928854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383518303745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2211383518303745"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2018.09.003","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}